2-methoxy-4-prop-1-enylphenyl acetate: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
isoeugenol acetate : A phenylpropanoid that is the acetate ester of trans-isoeugenol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 876160 |
| CHEMBL ID | 1609480 |
| CHEBI ID | 86583 |
| MeSH ID | M0352281 |
| Synonym |
|---|
| [2-methoxy-4-[(e)-prop-1-enyl]phenyl] acetate |
| acetoisoeugenol |
| AKOS015837939 |
| phenol, 2-methoxy-4-(1-propenyl)-, acetate, (e)- |
| 2-methoxy-4-[(1e)-1-propenyl]phenyl acetate |
| phenol, 2-methoxy-4-(1-propenyl)-, acetate |
| isoeugenyl acetate 1 |
| phenol, 2-methoxy-4-propenyl-, acetate |
| 93-29-8 |
| nsc46121 |
| nsc-46121 |
| wln: 2u1r co1 dov1 |
| 2-methoxy-4-propenylphenyl acetate |
| 4-acetoxy-3-methoxy-1-propenylbenzene |
| acetisoeugenol |
| acetylisoeugenol |
| isoeugenyl acetate , |
| isoeugenol, acetate |
| 2-methoxy-4-prop-1-enylphenyl acetate |
| ai3-24267 |
| nsc 46121 |
| 4-acetoxy-3-methoxy-1-(1-propen-1-yl)benzene |
| isoeugenol acetate |
| 2-methoxy-4-(1-propenyl)phenyl acetate |
| einecs 202-236-1 |
| acetyl isoeugenol |
| fema no. 2470 |
| MLS000563467 |
| smr000105317 |
| isoeugenyl acetate, >=98%, fcc, fg |
| isoeugenylacetate |
| A1184 |
| 1-acetoxy-2-methoxy-4-(1-propenyl)benzene |
| 1-(3-methoxy-4-acetoxyphenyl)-1-propene |
| BMSE010051 |
| 2-methoxy-4-(prop-1-en-1-yl)phenyl acetate |
| A844512 |
| NCGC00247539-01 |
| phenol, 2-methoxy-4-(1-propen-1-yl)-, 1-acetate |
| 9df21gi8w6 , |
| unii-9df21gi8w6 |
| HMS2225L23 |
| phenol, 2-methoxy-4-(1e)-1-propen-1-yl-, 1-acetate |
| isoeugenyl acetate, (e)- |
| unii-7xk69tok59 |
| phenol, 2-methoxy-4-propenyl-, acetate, (e)- |
| phenol, 2-methoxy-4-(1e)-1-propenyl-, acetate |
| trans-isoeugenol acetate |
| (e)-isoeugenyl acetate |
| 7xk69tok59 , |
| 5912-87-8 |
| 2-(methyloxy)-4-[(1e)-prop-1-enyl]phenyl acetate |
| o-acetylisoeugenol |
| chebi:86583 , |
| CHEMBL1609480 |
| W-109345 |
| 2-methoxy-4-[(1e)-prop-1-en-1-yl]phenyl acetate |
| mfcd00026984 |
| isoeugenyl acetate, analytical standard |
| sr-01000221703 |
| SR-01000221703-1 |
| (e)-2-methoxy-4-(prop-1-en-1-yl)phenyl acetate |
| Q27159265 |
| (e)-2-methoxy-4-(prop-1-enyl)phenyl acetate |
| HY-N6805 |
| CS-W021012 |
| 1-acetoxy-2-methoxy-4-trans-propenyl-benzene |
| BS-51311 |
| DTXSID601020590 |
| 1-acetoxy-2-methoxy-4-[(e)-1-propenyl]benzene |
| (e)-isoeugenol acetate |
| 2-methoxy-4-(prop-1-en-1-yl)phenylacetate |
| bestally |
| acetyl iso eugenol |
| kunshan asia aroma |
| isoeugenyl acetate 908 |
| iso eugenyl acetate |
| a00615 |
| Class | Description |
|---|---|
| phenylpropanoid | Any organic aromatic compound with a structure based on a phenylpropane skeleton. The class includes naturally occurring phenylpropanoid esters, flavonoids, anthocyanins, coumarins and many small phenolic molecules as well as their semi-synthetic and synthetic analogues. Phenylpropanoids are also precursors of lignin. |
| monomethoxybenzene | Compounds containing a benzene skeleton substituted with one methoxy group. |
| phenyl acetates | An acetate ester obtained by formal condensation of the carboxy group of acetic acid with the hydroxy group of any phenol. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 0.2239 | 0.0447 | 17.8581 | 100.0000 | AID485294 |
| 67.9K protein | Vaccinia virus | Potency | 12.5893 | 0.0001 | 8.4406 | 100.0000 | AID720579 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | Homo sapiens (human) | Potency | 100.0000 | 3.5481 | 19.5427 | 44.6684 | AID743266 |
| serine/threonine-protein kinase PLK1 | Homo sapiens (human) | Potency | 21.1923 | 0.1683 | 16.4040 | 67.0158 | AID720504 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Potency | 100.0000 | 0.4256 | 12.0591 | 28.1838 | AID504891 |
| DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 56.2341 | 0.0501 | 27.0736 | 89.1251 | AID588590 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | |||
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | |||
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 12 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||